NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ('NurExone” or the 'Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system ...

Near-term – Closing and funding of the Quazar Investment of $50 million.

Co-op programs in health-care spaces regularly enlist post-secondary students, but some are skewing younger to target high ...

Lithuanian-Manufactured Bilateral Cervical Vagus Nerve Stimulator Leads Consumer Wellness Category With 100,000+ Verified ...

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...

This milestone follows the Company’s recent announcement of positive results from a 24-patient cohort treated with NEO100. The findings were presented to the investment community during NeOnc’s ...

NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...

Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with ...

Nuvation Bio Inc. is rated a Hold due to recent price surge and near-term volatility, awaiting clearer sales data. Learn more ...

Learn more about whether Immunocore Holdings plc or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

It may sound surprising but kids can get diseases like lupus and arthritis, too, when their immune system mistakenly attacks their own body. With the exception of Type 1 diabetes, autoimmune ...

Autoimmune diseases like lupus, myositis and forms of arthritis can strike children, too. At a sleepaway camp in upstate New York, some young patients got a chance to ...